Ignite Creation Date:
2025-12-24 @ 1:40 PM
Ignite Modification Date:
2026-02-27 @ 5:09 PM
Study NCT ID:
NCT04108195
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-12-05
First Post:
2019-09-26
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study of Subcutaneous Daratumumab Regimens in Combination With Bispecific T Cell Redirection Antibodies for the Treatment of Participants With Multiple Myeloma
Sponsor:
Janssen Research & Development, LLC
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-02-21
Start Date Type:
ACTUAL
Primary Completion Date:
2027-04-07
Primary Completion Date Type:
ESTIMATED
Completion Date:
2027-04-07
Completion Date Type:
ESTIMATED
First Submit Date:
2019-09-26
First Submit QC Date:
None
Study First Post Date:
2019-09-30
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-12-04
Last Update Post Date:
2025-12-05
Last Update Post Date Type:
ESTIMATED